Provider review · Updated October 5, 2026
SuperHealthy Rx review: what its catalog means for a pore-care search
A review of the linked telehealth offer, with a clear boundary: the checked catalog does not establish a pore-care cream or dermatology service.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
SuperHealthy Rx appears in this publication’s featured-provider directory. For a reader arriving from a clogged-pores search, the first question is therefore unusually important: does the service actually offer the skincare product being compared? The public catalog and linked campaign checked on October 5, 2026 did not establish that offer.
This native review documents the service that is advertised and explains where the comparison stops. It does not invent a topical formula, a skin consultation or an acne result. We read public pages without completing an intake, making a purchase or testing the support and pharmacy workflow.
In this article
The catalog is broader telehealth, not a pore-product label
The main site lists weight care and other treatment categories, including NAD+ and sermorelin. A catalog entry records what a provider advertises; it does not establish the suitability or evidence for every category. The particular campaign linked from this review concerns compounded weight-care injections. Catalog and linked campaign.
No Clear Skin-type cream, salicylic-acid panel or pore-focused clinical service was verified in those pages. A reader seeking a topical product should compare that missing scope before comparing any price. The Likeness cream review and CoreAge Pore Favor record address identifiable skincare offers instead.
What the linked prices actually describe
The campaign displays $85 per month for compounded semaglutide and $135 per month for compounded tirzepatide. It describes a provider visit and shipping as included. These are weight-care advertising terms. They are not a price for a skin assessment, face cream or combined dermatology subscription. Offer and inclusions.
A useful personal budget still needs the selected checkout amount, billing frequency and any applicable conditions. We have not entered a patient-specific checkout, so the advertised headline cannot establish the terms of an individual order. Reading the shopping checklist can help distinguish a public price from the final agreement without treating unlike services as substitutes.
The current refill wording needs its own reading
The campaign says auto-refill keeps treatment arriving and can be turned off before an order. We do not describe this as a guaranteed one-time purchase or promise that enrollment is opt-in after the first shipment. Confirm the actual setting, next charge and method of stopping future orders for the plan you select. Current billing answer.
The absence of a membership fee does not by itself establish the absence of a recurring medication charge. Keep those concepts separate. A reader should be able to explain what renews, what can be canceled and which order has already entered fulfillment before deciding that a program is flexible enough for their circumstances.
Eligibility language is not a universal refund promise
The offer describes a refund when treatment is not clinically appropriate. It also includes order-specific terms about billing and cancellation. That public statement does not establish that every dissatisfaction after approval or shipment is refundable. Ask how the rule applies to the selected order and which amounts, if any, remain payable after assessment. Eligibility and terms.
This distinction is especially relevant when comparing a telehealth program with an ordinary retail product. A consultation, a dispensed prescription and a bottle bought off a shelf can have different cancellation and return processes. Our comparison by format keeps those records apart instead of assigning a single return-policy score.
What the clinical process statement establishes
The campaign describes health-history review by a licensed provider followed by pharmacy dispensing if prescribing is appropriate. We did not verify the professional assigned to an individual request, the response time for a medication question or the handling of a clinical escalation. Those remain service questions for enrollment, not measured findings from this review. Advertised care process.
A weight-care history form should not be assumed to include a dermatologic evaluation. If the actual concern is a persistent rash, new lesion or an unexplained skin change, identify the relevant care pathway rather than infer it from a broad telehealth brand name. No selection in this site’s reading tool sends symptoms to a clinician or establishes a diagnosis.
Why the compounded-drug distinction belongs here
The linked offer identifies compounded medicines. FDA does not approve these preparations or review them for safety, effectiveness and quality before marketing. This regulatory distinction applies to the advertised preparation; it is not a finding that we inspected a specific pharmacy batch or compared it with an approved drug. FDA compounding explanation.
We do not translate a sales-page delivery promise, certification badge or customer count into a medical outcome score. Those items answer different questions and require their own verification. A credible account of service experience would also require evidence from actual enrollment and follow-up, which this public-source review does not claim to provide.
How to use the second featured position
CoreAge appears first, SuperHealthy second and Likeness third in the directory. Those positions and associated scores reflect publisher preference and commercial placement. They are not patient-review averages, a trial result or proof that the second entry offers every service available from the first. The full explanation is in our disclosure.
For pore-care reading, the practical value of this record is its boundary. It prevents a reader from carrying a weight-care headline into a skincare comparison. The online-provider guide contrasts verified topical offers with this unverified skincare scope, while the product reviews retain their own ingredients and evidence questions.
What would justify updating this review
A new public skincare page would need to identify the preparation or visit type, the advertised concern, the prescribing route and the relevant pricing. We would then check that source and describe the limits of the specific offer. A menu expansion alone would not establish that a preparation works for a particular skin concern.
Until then, readers can use the visible-pores explanation to clarify the subject of their search and follow the existing product records for actual topical comparisons. The external SuperHealthy weight-care campaign is included as the reviewed offer, with its service category stated explicitly.
Sources behind this reading
- SuperHealthy Rx: public treatment catalog ↗Provider catalog · Checked October 5, 2026
- SuperHealthy Rx: linked weight-care offer and billing statements ↗Provider campaign · Checked October 5, 2026
- FDA: compounding questions and answers ↗Regulator explanation · Checked October 5, 2026